TY - JOUR
T1 - Muslim communities learning about second-hand smoke (MCLASS)
T2 - study protocol for a pilot cluster randomised controlled trial
AU - Ainsworth, Hannah
AU - Shah, Sarwat
AU - Ahmed, Faraz
AU - Amos, Amanda
AU - Cameron, Ian
AU - Fairhurst, Caroline Marie
AU - King, Rebecca
AU - Mir, Ghazala
AU - Parrott, Steve
AU - Sheikh, Aziz
AU - Torgerson, David
AU - Thomson, Heather
AU - Siddiqi, Kamran
N1 - © 2013 Ainsworth et al.
PY - 2013/9/13
Y1 - 2013/9/13
N2 - In the UK, 40% of Bangladeshi and 29% of Pakistani men smoke cigarettes regularly compared to the national average of 24%. As a consequence, second-hand smoking is also widespread in their households which is a serious health hazard to non-smokers, especially children. Smoking restrictions in households can help reduce exposure to second-hand smoking. This is a pilot trial of 'Smoke Free Homes', an educational programme which has been adapted for use by Muslim faith leaders, in an attempt to find an innovative solution to encourage Pakistani- and Bangladeshi-origin communities to implement smoking restrictions in their homes. The primary objectives for this pilot trial are to establish the feasibility of conducting such an evaluation and provide information to inform the design of a future definitive study.
AB - In the UK, 40% of Bangladeshi and 29% of Pakistani men smoke cigarettes regularly compared to the national average of 24%. As a consequence, second-hand smoking is also widespread in their households which is a serious health hazard to non-smokers, especially children. Smoking restrictions in households can help reduce exposure to second-hand smoking. This is a pilot trial of 'Smoke Free Homes', an educational programme which has been adapted for use by Muslim faith leaders, in an attempt to find an innovative solution to encourage Pakistani- and Bangladeshi-origin communities to implement smoking restrictions in their homes. The primary objectives for this pilot trial are to establish the feasibility of conducting such an evaluation and provide information to inform the design of a future definitive study.
U2 - 10.1186/1745-6215-14-295
DO - 10.1186/1745-6215-14-295
M3 - Article
C2 - 24034853
SN - 1745-6215
VL - 14
SP - 1
EP - 11
JO - Trials
JF - Trials
IS - 1
M1 - 295
ER -